Imidazoler
Filtrerade sökresultat
1-Methylimidazole, 99%
CAS: 616-47-7 Molekylformel: C4H6N2 Molekylvikt (g/mol): 82.11 MDL-nummer: MFCD00005292 InChI-nyckel: MCTWTZJPVLRJOU-UHFFFAOYSA-N Synonym: 1-methyl-1h-imidazole,n-methylimidazole,1h-imidazole, 1-methyl,imidazole, 1-methyl,n-methyl imidazole,1-methyl-imidazole,unii-p4617qs63y,1-methyl-1h-imidazol,n-methylimidazol,1-methylimdazole PubChem CID: 1390 ChEBI: CHEBI:113454 IUPAC-namn: 1-metylimidazol LEDER: CN1C=CN=C1
| Molekylformel | C4H6N2 |
|---|---|
| PubChem CID | 1390 |
| MDL-nummer | MFCD00005292 |
| IUPAC-namn | 1-metylimidazol |
| CAS | 616-47-7 |
| InChI-nyckel | MCTWTZJPVLRJOU-UHFFFAOYSA-N |
| LEDER | CN1C=CN=C1 |
| ChEBI | CHEBI:113454 |
| Molekylvikt (g/mol) | 82.11 |
| Synonym | 1-methyl-1h-imidazole,n-methylimidazole,1h-imidazole, 1-methyl,imidazole, 1-methyl,n-methyl imidazole,1-methyl-imidazole,unii-p4617qs63y,1-methyl-1h-imidazol,n-methylimidazol,1-methylimdazole |
1-etyl-3-metylimidazoliumdicyanamid, 98 %, Thermo Scientific Chemicals
CAS: 370865-89-7 Molekylformel: C8H11N5 Molekylvikt (g/mol): 177.211 MDL-nummer: MFCD08276373 InChI-nyckel: MKHFCTXNDRMIDR-UHFFFAOYSA-N Synonym: 1-ethyl-3-methylimidazolium dicyanamide,ethylmethylimidazolium dicyanamide,emim dca,acmc-209iqn,basionics™ vs 03,dsstox_cid_27940,dsstox_rid_82692,dsstox_gsid_47964,ksc221g0h PubChem CID: 11159638 IUPAC-namn: cyanoiminometylidenazanid;1-etyl-3-metylimidazol-3-ium LEDER: CCN1C=C[N+](=C1)C.C(=[N-])=NC#N
| Molekylformel | C8H11N5 |
|---|---|
| PubChem CID | 11159638 |
| MDL-nummer | MFCD08276373 |
| IUPAC-namn | cyanoiminometylidenazanid;1-etyl-3-metylimidazol-3-ium |
| CAS | 370865-89-7 |
| InChI-nyckel | MKHFCTXNDRMIDR-UHFFFAOYSA-N |
| LEDER | CCN1C=C[N+](=C1)C.C(=[N-])=NC#N |
| Molekylvikt (g/mol) | 177.211 |
| Synonym | 1-ethyl-3-methylimidazolium dicyanamide,ethylmethylimidazolium dicyanamide,emim dca,acmc-209iqn,basionics™ vs 03,dsstox_cid_27940,dsstox_rid_82692,dsstox_gsid_47964,ksc221g0h |
Thermo Scientific Chemicals 1-metylimidazol, för biokemi, vattenfri, AcroSeal™
CAS: 616-47-7 Molekylformel: C4H6N2 Molekylvikt (g/mol): 82.11 MDL-nummer: MFCD00005292 InChI-nyckel: MCTWTZJPVLRJOU-UHFFFAOYSA-N IUPAC-namn: 1-metyl-lH-imidazol LEDER: CN1C=CN=C1
| Molekylformel | C4H6N2 |
|---|---|
| MDL-nummer | MFCD00005292 |
| IUPAC-namn | 1-metyl-lH-imidazol |
| CAS | 616-47-7 |
| InChI-nyckel | MCTWTZJPVLRJOU-UHFFFAOYSA-N |
| LEDER | CN1C=CN=C1 |
| Molekylvikt (g/mol) | 82.11 |
1,2-Dimethylimidazole, 96+%
CAS: 1739-84-0 Molekylformel: C5H8N2 Molekylvikt (g/mol): 96.13 MDL-nummer: MFCD00005294 InChI-nyckel: GIWQSPITLQVMSG-UHFFFAOYSA-N Synonym: 1,2-dimethyl-1h-imidazole,1h-imidazole, 1,2-dimethyl,imidazole, 1,2-dimethyl,1h-imidazole, dimethyl,unii-q41bc3grjb,q41bc3grjb,lupragen r dmi,1,2-dimethylimdazole,1,2 dimethylimidazole,n,2-dimethylimidazole PubChem CID: 15617 IUPAC-namn: 1,2-dimetylimidazol LEDER: CN1C=CN=C1C
| Molekylformel | C5H8N2 |
|---|---|
| PubChem CID | 15617 |
| MDL-nummer | MFCD00005294 |
| IUPAC-namn | 1,2-dimetylimidazol |
| CAS | 1739-84-0 |
| InChI-nyckel | GIWQSPITLQVMSG-UHFFFAOYSA-N |
| LEDER | CN1C=CN=C1C |
| Molekylvikt (g/mol) | 96.13 |
| Synonym | 1,2-dimethyl-1h-imidazole,1h-imidazole, 1,2-dimethyl,imidazole, 1,2-dimethyl,1h-imidazole, dimethyl,unii-q41bc3grjb,q41bc3grjb,lupragen r dmi,1,2-dimethylimdazole,1,2 dimethylimidazole,n,2-dimethylimidazole |
4-Nitroimidazole, 98%
CAS: 3034-38-6 Molekylformel: C3H3N3O2 Molekylvikt (g/mol): 113.08 MDL-nummer: MFCD00005196 InChI-nyckel: VYDWQPKRHOGLPA-UHFFFAOYSA-N Synonym: 4-nitroimidazole,4-nitro-1h-imidazole,1h-imidazole, 4-nitro,5-nitroimidazole,4 5-nitroimidazole,imidazole, 4-nitro,1h-imidazole, 5-nitro,unii-y8u32az5o7,5 4-nitroimidazole,4-nitro-3h-imidazole PubChem CID: 18208 ChEBI: CHEBI:64635 IUPAC-namn: 5-nitro-lH-imidazol LEDER: [O-][N+](=O)C1=CN=CN1
| Molekylformel | C3H3N3O2 |
|---|---|
| PubChem CID | 18208 |
| MDL-nummer | MFCD00005196 |
| IUPAC-namn | 5-nitro-lH-imidazol |
| CAS | 3034-38-6 |
| InChI-nyckel | VYDWQPKRHOGLPA-UHFFFAOYSA-N |
| LEDER | [O-][N+](=O)C1=CN=CN1 |
| ChEBI | CHEBI:64635 |
| Molekylvikt (g/mol) | 113.08 |
| Synonym | 4-nitroimidazole,4-nitro-1h-imidazole,1h-imidazole, 4-nitro,5-nitroimidazole,4 5-nitroimidazole,imidazole, 4-nitro,1h-imidazole, 5-nitro,unii-y8u32az5o7,5 4-nitroimidazole,4-nitro-3h-imidazole |
Pracinostat, MedChemExpress
MedChemExpress Pracinostat is a potent histone deacetylase (HDAC) inhibitor, with IC50s of 40-140 nM, used for cancer research.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C20H30N4O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 358.48 |
| Hållbarhet | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 250 mg/mL (697.39 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 929016-96-6 |
| LEDER | ONC(/C=C/C1=CC=C2N(C(CCCC)=NC2=C1)CCN(CC)CC)=O |
| Molekylvikt (g/mol) | 358.48 |
| Synonym | SB939 |
| Kemiskt namn eller material | Pracinostat |
| Procent renhet | 98.83% |
| För användning med (applikation) | Cancer-programmed cell death |
GSK840, MedChemExpress
MedChemExpress GSK840 (GSK'840) is a receptor-interacting protein kinase 3 (RIP3 or RIPK3) inhibitor, which binds RIP3 kinase domain with an IC50 of 0.9 nM, and inhibits kinase activity with an IC50 of 0.3 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C21H23N3O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 365.43 |
| Hållbarhet | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 110 mg/mL (301.02 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Light Yellow |
| CAS | 2361146-30-5 |
| LEDER | O=C(OC(C)(C)C)CC1=CC=C(N2C3=CC=C(C(NC)=O)C=C3N=C2)C=C1 |
| Molekylvikt (g/mol) | 365.43 |
| Synonym | GSK'840 |
| Kemiskt namn eller material | GSK840 |
| Procent renhet | 98.0% |
| För användning med (applikation) | COVID-19-immunoregulation |
SKL2001, MedChemExpress
MedChemExpress SKL2001 is an agonist of the Wnt/β-catenin pathway, with anti-cancer activity. SKL2001 stabilizes intracellular β-catenin via disruption of the Axin/β-catenin interaction.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C14H14N4O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 286.29 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 96.66 mg/mL (337.63 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 909089-13-0 |
| LEDER | O=C(C1=NOC(C2=CC=CO2)=C1)NCCCN3C=CN=C3 |
| Molekylvikt (g/mol) | 286.29 |
| Kemiskt namn eller material | SKL2001 |
| Procent renhet | 99.54% |
| För användning med (applikation) | Cancer-programmed cell death |
EF-5, MedChemExpress
MedChemExpress EF-5 (EF5; 2-Nitroimidazole) is a hypoxia labeling agent used to identify hypoxia in cells.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C8H7F5N4O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 302.16 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 125 mg/mL (413.69 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 152721-37-4 |
| LEDER | O=C(NCC(F)(F)C(F)(F)F)CN1C=CN=C1[N+]([O-])=O |
| Molekylvikt (g/mol) | 302.16 |
| Kemiskt namn eller material | EF-5 |
| Procent renhet | 98.0% |
| För användning med (applikation) | Cancer-programmed cell death |
StemRegenin 1, MedChemExpress
MedChemExpress StemRegenin 1 is a potent aryl hydrocarbon receptor (AhR) antagonist with IC50 of 127 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C24H23N5OS |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 429.54 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 100 mg/mL (232.81 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 1227633-49-9 |
| LEDER | CC(C)N1C2=NC(C3=CSC4=C3C=CC=C4)=NC(NCCC5=CC=C(O)C=C5)=C2N=C1 |
| Molekylvikt (g/mol) | 429.54 |
| Synonym | SR1 |
| Kemiskt namn eller material | StemRegenin 1 |
| Procent renhet | 97.0% |
| För användning med (applikation) | Cancer-programmed cell death |
trans-Zeatinriboside, MedChemExpress
MedChemExpress trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C15H21N5O5 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 351.36 |
| Hållbarhet | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Hälsofara 1 | H302∣H315∣H319∣H335 |
| Löslighetsinformation | DMSO : ≥ 100 mg/mL (284.61 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 6025-53-2 |
| LEDER | C/C(CO)=C\CNC1=C(N=CN2[C@H]3[C@H](O)[C@H](O)[C@H](O3)CO)C2=NC=N1 |
| Molekylvikt (g/mol) | 351.36 |
| Kemiskt namn eller material | trans-Zeatinriboside |
| Procent renhet | 99.51% |
Purvalanol B, MedChemExpress
MedChemExpress Purvalanol B (NG 95) is a potent, selective, reversible and ATP-competitive inhibitor CDK, with IC50s of 6 nM, 6 nM, 9 nM, 6 nM for cdc2-cyclin B, CDK2-cyclin A, CDK2-cyclin E and CDK5-p35, respectively. Purvalanol B shows selectivity for CDK over a range of other protein kinases (IC50>1000 nM). Purvalanol B inhibits the growth a chloroquine-resistant strain of P. falciparum.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C20H25ClN6O3 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 432.9 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 40 mg/mL (92.40 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | White |
| CAS | 212844-54-7 |
| LEDER | O=C(O)C1=CC=C(NC2=C3N=CN(C(C)C)C3=NC(N[C@@H](CO)C(C)C)=N2)C=C1Cl |
| Molekylvikt (g/mol) | 432.9 |
| Synonym | NG 95 |
| Kemiskt namn eller material | Purvalanol B |
| Procent renhet | 95.0% |
| För användning med (applikation) | Cancer-Kinase/protease |
MRS-1706, MedChemExpress
MedChemExpress MRS-1706 is a potent and selective adenosine A2B receptor inverse agonist. MRS-1706 has Ki values of 1.39, 112, 157, and 230 nM for human A2B, A2A, A1 and A3 receptors respectively. MRS-1706 blocks adenosine-mediated cAMP induction.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C27H29N5O5 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 503.55 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 240 mg/mL (476.62 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 264622-53-9 |
| LEDER | O=C(NC1=CC=C(C(C)=O)C=C1)COC2=CC=C(C3=NC(N(CCC)C(N(CCC)C4=O)=O)=C4N3)C=C2 |
| Molekylvikt (g/mol) | 503.55 |
| Kemiskt namn eller material | MRS-1706 |
| Procent renhet | 98.23% |
| För användning med (applikation) | COVID-19-immunoregulation |
Quizartinib, MedChemExpress
MedChemExpress Quizartinib (AC220) is an orally active, highly selective and potent second-generation type II FLT3 tyrosine kinase inhibitor, with a Kd of 1.6 nM. Quizartinib inhibits wild-type FLT3 and FLT3-ITD autophosphorylation in MV4-11 cells with IC50s of 4.2 and 1.1 nM, respectively. Quizartinib can be linked to the VHL ligand via an optimized linker to form a PROTAC FLT3 degrader. Quizartinib induces apoptosis.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C29H32N6O4S |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 560.67 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : ≥ 33 mg/mL (58.86 mM) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 950769-58-1 |
| LEDER | O=C(NC1=NOC(C(C)(C)C)=C1)NC2=CC=C(C=C2)C3=CN4C(SC5=CC(OCCN6CCOCC6)=CC=C45)=N3 |
| Molekylvikt (g/mol) | 560.67 |
| Synonym | AC220 |
| Kemiskt namn eller material | Quizartinib |
| Procent renhet | 98.87% |
| För användning med (applikation) | Cancer-Kinase/protease |
Y06137, MedChemExpress
MedChemExpress Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC). Y06137 binds to the BRD4(1) bromodomain with a Kd of 81 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molekylformel | C27H32N4O2 |
|---|---|
| Rekommenderad förvaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Formel vikt | 444.57 |
| Hållbarhet | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Löslighetsinformation | DMSO : 62.5 mg/mL (140.59 mM; Need ultrasonic) |
| Anteckningar om renhetsgrad | Research |
| Fysisk form | Solid |
| Kvalitet | Research |
| Färg | Off-White |
| CAS | 2226534-49-0 |
| LEDER | CC1=NOC(C1=C2)=CC=C2C3=NC(C=C4)=C(N3CC5CCCCC5)C=C4N6CCOC[C@@H]6C |
| Molekylvikt (g/mol) | 444.57 |
| Kemiskt namn eller material | Y06137 |
| Procent renhet | 99.9% |
| För användning med (applikation) | Neuroscience-Neuromodulation |